|
|
| G
|
Ache
|
acetylcholinesterase
|
multiple interactions
|
ISO
|
protopanaxadiol inhibits the reaction [Scopolamine results in increased activity of ACHE protein]
|
CTD |
PMID:29133030 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of BCL2L1 mRNA
|
CTD |
PMID:31805304 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
affects expression
|
ISO
|
protopanaxadiol affects the expression of BIRC5 protein
|
CTD |
PMID:31805304 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
| G
|
Casp3
|
caspase 3
|
increases expression affects cleavage
|
ISO
|
protopanaxadiol results in increased expression of CASP3 mRNA protopanaxadiol affects the cleavage of CASP3 protein
|
CTD |
PMID:31805304 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
increases expression affects expression
|
ISO
|
protopanaxadiol results in increased expression of CASP9 mRNA protopanaxadiol affects the expression of CASP9 protein
|
CTD |
PMID:31805304 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Ccna2
|
cyclin A2
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of CCNA2 mRNA
|
CTD |
PMID:31805304 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccnb1
|
cyclin B1
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of CCNB1 mRNA
|
CTD |
PMID:31805304 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnd1
|
cyclin D1
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of CCND1 mRNA
|
CTD |
PMID:31805304 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Cdc25a
|
cell division cycle 25A
|
multiple interactions increases expression
|
ISO
|
protopanaxadiol results in increased expression of and results in decreased phosphorylation of CDC25A protein protopanaxadiol results in increased expression of CDC25A mRNA
|
CTD |
PMID:31805304 |
|
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188
|
|
| G
|
Cdc25c
|
cell division cycle 25C
|
increases expression multiple interactions
|
ISO
|
protopanaxadiol results in increased expression of CDC25C mRNA protopanaxadiol affects the expression of and affects the phosphorylation of CDC25C protein
|
CTD |
PMID:31805304 |
|
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of CDK1 mRNA
|
CTD |
PMID:31805304 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of CDK2 mRNA
|
CTD |
PMID:31805304 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of CDK4 mRNA; protopanaxadiol results in increased expression of CDK4 protein
|
CTD |
PMID:31805304 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Chat
|
choline O-acetyltransferase
|
multiple interactions
|
ISO
|
protopanaxadiol inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]
|
CTD |
PMID:29133030 |
|
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions decreases activity
|
ISO
|
protopanaxadiol results in decreased expression of and results in increased phosphorylation of EGFR protein protopanaxadiol results in decreased activity of EGFR protein
|
CTD |
PMID:31805304 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Egr1
|
early growth response 1
|
multiple interactions
|
ISO
|
protopanaxadiol inhibits the reaction [Scopolamine results in decreased expression of EGR1 protein]
|
CTD |
PMID:29133030 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
ISO
|
protopanaxadiol inhibits the reaction [Scopolamine results in decreased expression of FOS protein]
|
CTD |
PMID:29133030 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
ISO
|
protopanaxadiol inhibits the reaction [Scopolamine results in decreased expression of JUN protein]
|
CTD |
PMID:29133030 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Map2k1
|
mitogen activated protein kinase kinase 1
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of MAP2K1 mRNA
|
CTD |
PMID:31805304 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
decreases phosphorylation
|
ISO
|
protopanaxadiol results in decreased phosphorylation of MAPK1 protein
|
CTD |
PMID:31805304 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
decreases phosphorylation
|
ISO
|
protopanaxadiol results in decreased phosphorylation of MAPK3 protein
|
CTD |
PMID:31805304 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of PARP1 mRNA
|
CTD |
PMID:31805304 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Raf1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
increases phosphorylation
|
ISO
|
protopanaxadiol results in increased phosphorylation of RAF1 protein
|
CTD |
PMID:31805304 |
|
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813
|
|
| G
|
Rps6ka1
|
ribosomal protein S6 kinase A1
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of RPS6KA1 mRNA
|
CTD |
PMID:31805304 |
|
NCBI chr 5:151,362,819...151,402,064
Ensembl chr 5:151,362,819...151,476,044
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
affects expression
|
ISO
|
protopanaxadiol affects the expression of STAT3 protein
|
CTD |
PMID:31805304 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Tp53
|
tumor protein p53
|
increases expression
|
ISO
|
protopanaxadiol results in increased expression of TP53 mRNA; protopanaxadiol results in increased expression of TP53 protein
|
CTD |
PMID:31805304 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
|
| G
|
Aqp9
|
aquaporin 9
|
increases expression
|
ISO
|
cycloastragenol results in increased expression of AQP9 mRNA; cycloastragenol results in increased expression of AQP9 protein
|
CTD |
PMID:37918281 |
|
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240
|
|
| G
|
Arhgap17
|
Rho GTPase activating protein 17
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction decreases expression of Arhgap17 protein in myocardium]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 1:187,238,675...187,328,093
Ensembl chr 1:187,238,380...187,327,936
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction increases expression of Bax protein in myocardium]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Ccnd1
|
cyclin D1
|
increases expression
|
ISO
|
cycloastragenol results in increased expression of CCND1 protein
|
CTD |
PMID:37918281 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Dsc2
|
desmocollin 2
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction decreases expression of Dsc2 protein in myocardium]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction decreases expression of Gsk3b protein in myocardium]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction increases expression of Ifng protein in spleen]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Ikbkg
|
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction decreases expression of Ikbkg protein in myocardium]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:157,367,639...157,392,757
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction increases expression of Il10 protein in spleenocytes and peripheral blood]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il17a
|
interleukin 17A
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction increases expression of Il17 protein in spleenocytes and peripheral blood]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction increases expression of Il1b protein in spleenocytes and peripheral blood]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il4
|
interleukin 4
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction decreases expression of Il4 protein in spleen]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions
|
EXP ISO
|
cycloastragenol inhibits the reaction [acute myocardial infarction increases expression of Il6 protein in spleenocytes and peripheral blood] cycloastragenol inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased secretion of IL6 protein]
|
CTD RGD |
PMID:37579952 PMID:32068187 |
RGD:267358468 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions
|
ISO
|
cycloastragenol inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased secretion of MMP9 protein]
|
CTD |
PMID:37579952 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mt-co2
|
mitochondrially encoded cytochrome c oxidase II
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction increases expression of Mt-co2 protein in myocardium]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr MT:7,006...7,689
Ensembl chr MT:6,991...7,674
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
increases expression
|
ISO
|
cycloastragenol results in increased expression of PCNA protein
|
CTD |
PMID:37918281 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Plcg1
|
phospholipase C, gamma 1
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction increases expression of Plcg1 protein in myocardium]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:169,804,846...169,836,050
|
|
| G
|
Rhoa
|
ras homolog family member A
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction increases expression of Rhoa protein in myocardium]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302
|
|
| G
|
Rit2
|
Ras-like without CAAX 2
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction decreases expression of Rit2 protein in myocardium]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr18:22,839,914...23,196,137
Ensembl chr18:22,839,915...23,269,823
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
multiple interactions
|
ISO
|
cycloastragenol inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TERT protein]; cycloastragenol inhibits the reaction [Benzo(a)pyrene results in decreased expression of TERT protein]
|
CTD |
PMID:37579952 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction increases expression of Tnf protein in spleen]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Zeb1
|
zinc finger E-box binding homeobox 1
|
multiple interactions
|
EXP
|
cycloastragenol inhibits the reaction [acute myocardial infarction decreases expression of Zeb1 protein in myocardium]
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:56,644,397...56,810,745
|
|
|
|
| G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
multiple interactions increases expression
|
EXP
|
[Ethinyl Estradiol co-treated with Diosgenin] results in increased expression of ABCC2 mRNA Diosgenin results in increased expression of ABCC2 mRNA
|
CTD |
PMID:16105132 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
| G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
increases expression multiple interactions
|
EXP
|
Diosgenin results in increased expression of ABCC3 mRNA [Ethinyl Estradiol co-treated with Diosgenin] results in increased expression of ABCC3 mRNA
|
CTD |
PMID:16105132 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
|
|
| G
|
Abcg5
|
ATP binding cassette subfamily G member 5
|
increases expression multiple interactions
|
EXP ISO
|
Diosgenin results in increased expression of ABCG5 mRNA [Diosgenin results in increased expression of ABCG5 mRNA] which results in increased secretion of Cholesterol; [Ethinyl Estradiol co-treated with Diosgenin] results in decreased expression of ABCG5 mRNA Diosgenin promotes the reaction [ABCG5 protein results in increased secretion of Cholesterol]
|
CTD |
PMID:12963437 PMID:15611112 PMID:16105132 |
|
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376
|
|
| G
|
Abcg8
|
ATP binding cassette subfamily G member 8
|
increases expression multiple interactions
|
EXP ISO
|
Diosgenin results in increased expression of ABCG8 mRNA [Diosgenin results in increased expression of ABCG8 mRNA] which results in increased secretion of Cholesterol; [Ethinyl Estradiol co-treated with Diosgenin] results in decreased expression of ABCG8 mRNA Diosgenin promotes the reaction [ABCG8 protein results in increased secretion of Cholesterol]
|
CTD |
PMID:12963437 PMID:15611112 PMID:16105132 |
|
NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:15,698,448...15,717,730
|
|
| G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
decreases expression
|
ISO
|
Diosgenin results in decreased expression of ACACA mRNA
|
CTD |
PMID:32347045 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
|
|
| G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
multiple interactions
|
ISO
|
Diosgenin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]
|
CTD |
PMID:16331273 |
|
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929
|
|
| G
|
Acta2
|
actin alpha 2, smooth muscle
|
multiple interactions
|
EXP ISO
|
Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein] Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]]
|
CTD |
PMID:39059093 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
| G
|
Adam17
|
ADAM metallopeptidase domain 17
|
multiple interactions
|
EXP
|
Diosgenin inhibits the reaction [Streptozocin results in increased expression of ADAM17 mRNA]; Diosgenin inhibits the reaction [Streptozocin results in increased expression of ADAM17 protein]
|
CTD |
PMID:35305976 |
|
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
ISO
|
Diosgenin inhibits the reaction [TNF protein results in increased activity of AKT1 protein]
|
CTD |
PMID:16331273 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
multiple interactions
|
ISO
|
3-methyladenine inhibits the reaction [Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of APAF1 protein]]; Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of APAF1 protein]
|
CTD |
PMID:35149085 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
EXP
|
[morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in increased expression of BAX protein]; Diosgenin inhibits the reaction [Glucose results in increased expression of BAX protein]
|
CTD |
PMID:28106847 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases expression
|
ISO EXP
|
Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2 protein] [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Diosgenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein] Diosgenin results in decreased expression of BCL2 protein
|
CTD |
PMID:16331273 PMID:28106847 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2a1
|
BCL2-related protein A1
|
multiple interactions decreases expression
|
ISO
|
Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] Diosgenin results in decreased expression of BCL2A1 protein
|
CTD |
PMID:16331273 |
|
NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
decreases expression multiple interactions
|
ISO
|
Diosgenin results in decreased expression of BCL2L1 protein Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein]
|
CTD |
PMID:16331273 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Birc2
|
baculoviral IAP repeat-containing 2
|
multiple interactions decreases expression
|
ISO
|
Diosgenin inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] Diosgenin results in decreased expression of BIRC2 protein
|
CTD |
PMID:16331273 |
|
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions
|
ISO EXP
|
Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased activity of CASP3 protein] [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; Diosgenin inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]
|
CTD |
PMID:28106847 PMID:35149085 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
3-methyladenine inhibits the reaction [Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased activity of CASP9 protein]]; 3-methyladenine inhibits the reaction [Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased cleavage of CASP9 protein]]; Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased activity of CASP9 protein]; Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased cleavage of CASP9 protein]; Diosgenin promotes the reaction [alpha-Chlorohydrin results in increased expression of CASP9 protein]
|
CTD |
PMID:35149085 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
decreases expression multiple interactions
|
ISO
|
Diosgenin results in decreased expression of CCL2 mRNA Diosgenin inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA]
|
CTD |
PMID:26408789 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccnd1
|
cyclin D1
|
multiple interactions
|
ISO
|
Diosgenin inhibits the reaction [TNF protein results in increased expression of CCND1 protein]
|
CTD |
PMID:16331273 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Cdh5
|
cadherin 5
|
multiple interactions
|
EXP ISO
|
Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH5 protein] Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH5 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH5 protein]]
|
CTD |
PMID:39059093 |
|
NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822
|
|
| G
|
Ces1d
|
carboxylesterase 1D
|
multiple interactions
|
EXP
|
Diosgenin affects the reaction [Dietary Fats affects the expression of CES1 mRNA]; Diosgenin affects the reaction [Dietary Fats affects the expression of CES1 protein]
|
CTD |
PMID:33383043 |
|
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
|
|
| G
|
Cflar
|
CASP8 and FADD-like apoptosis regulator
|
decreases expression multiple interactions
|
ISO
|
Diosgenin results in decreased expression of CFLAR protein Diosgenin inhibits the reaction [TNF protein results in increased expression of CFLAR protein]
|
CTD |
PMID:16331273 |
|
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
multiple interactions
|
EXP
|
Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of COL1A1 mRNA]
|
CTD |
PMID:39059093 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col3a1
|
collagen type III alpha 1 chain
|
multiple interactions
|
EXP
|
Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of COL3A1 mRNA]
|
CTD |
PMID:39059093 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
decreases expression
|
ISO
|
Diosgenin results in decreased expression of CTNNB1 mRNA
|
CTD |
PMID:26408789 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1
|
multiple interactions
|
EXP
|
Diosgenin promotes the reaction [Dietary Fats results in increased expression of CYP27A1 mRNA]
|
CTD |
PMID:33383043 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
multiple interactions
|
EXP
|
[Ethinyl Estradiol co-treated with Diosgenin] results in increased expression of CYP7A1 mRNA; Diosgenin promotes the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA]; Diosgenin promotes the reaction [Dietary Fats results in increased expression of CYP7A1 protein]
|
CTD |
PMID:12963437 PMID:33383043 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Dnm1l
|
dynamin 1-like
|
multiple interactions
|
ISO EXP
|
Diosgenin affects the reaction [alpha-Chlorohydrin affects the localization of DNM1L protein] Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of DNM1L protein]
|
CTD |
PMID:35149085 |
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
|
|
| G
|
Eif4ebp1
|
eukaryotic translation initiation factor 4E binding protein 1
|
multiple interactions
|
ISO
|
3-methyladenine inhibits the reaction [Diosgenin promotes the reaction [alpha-Chlorohydrin results in decreased phosphorylation of EIF4EBP1 protein]]; Diosgenin promotes the reaction [alpha-Chlorohydrin results in decreased phosphorylation of EIF4EBP1 protein]
|
CTD |
PMID:35149085 |
|
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
|
|
| G
|
Esr2
|
estrogen receptor 2
|
multiple interactions increases expression
|
ISO
|
Diosgenin inhibits the reaction [Dietary Fats results in decreased expression of ESR2 protein]; Diosgenin promotes the reaction [RXRA protein binds to ESR2 protein] Diosgenin results in increased expression of ESR2 protein
|
CTD |
PMID:26408789 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Fabp4
|
fatty acid binding protein 4
|
decreases expression multiple interactions
|
ISO
|
Diosgenin results in decreased expression of FABP4 mRNA Diosgenin inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]; fulvestrant inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]; PPARG protein inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]; rosiglitazone inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]
|
CTD |
PMID:26408789 |
|
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
decreases expression
|
ISO
|
Diosgenin results in decreased expression of FAS mRNA
|
CTD |
PMID:32347045 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Fasn
|
fatty acid synthase
|
multiple interactions
|
ISO EXP
|
Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN protein]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN protein]] Diosgenin inhibits the reaction [Dietary Fats results in increased expression of FASN mRNA]; Diosgenin inhibits the reaction [Dietary Fats results in increased expression of FASN protein]
|
CTD |
PMID:39536891 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fgf19
|
fibroblast growth factor 19
|
multiple interactions
|
EXP
|
Diosgenin inhibits the reaction [Dietary Fats results in increased expression of FGF19 mRNA]
|
CTD |
PMID:33383043 |
|
NCBI chr 1:209,485,813...209,490,267
Ensembl chr 1:209,485,813...209,490,267
|
|
| G
|
Fis1
|
fission, mitochondrial 1
|
multiple interactions
|
ISO
|
Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of FIS1 protein]
|
CTD |
PMID:35149085 |
|
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
EXP
|
Diosgenin inhibits the reaction [Dietary Fats results in increased expression of GPT protein]
|
CTD |
PMID:39536891 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions
|
ISO EXP
|
Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A protein]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A protein]] Diosgenin inhibits the reaction [Dietary Fats results in increased expression of HIF1A mRNA]; Diosgenin inhibits the reaction [Dietary Fats results in increased expression of HIF1A protein]
|
CTD |
PMID:39536891 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
multiple interactions
|
ISO
|
[Diosgenin co-treated with Ecdysterone] results in increased expression of IGF1 mRNA
|
CTD |
PMID:39395682 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP ISO
|
Diosgenin inhibits the reaction [Dietary Fats results in increased expression of IL1B protein]; Diosgenin inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA]; Diosgenin inhibits the reaction [Streptozocin results in increased expression of IL1B protein] Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]; Diosgenin inhibits the reaction [MTOR protein promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]
|
CTD |
PMID:35305976 PMID:39536891 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions decreases expression
|
ISO EXP
|
Diosgenin inhibits the reaction [Dietary Fats results in increased expression of IL6 mRNA] Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL6 protein]; Diosgenin inhibits the reaction [Streptozocin results in increased expression of IL6 mRNA]; Diosgenin inhibits the reaction [Streptozocin results in increased expression of IL6 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL6 protein]] Diosgenin results in decreased expression of IL6 mRNA
|
CTD |
PMID:26408789 PMID:35305976 PMID:39059093 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Ins1
|
insulin 1
|
multiple interactions
|
EXP
|
Diosgenin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of INS1 protein]; Diosgenin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein]
|
CTD |
PMID:24001619 PMID:35305976 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
| G
|
Ldha
|
lactate dehydrogenase A
|
multiple interactions
|
EXP
|
Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of LDHA protein]
|
CTD |
PMID:39059093 |
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
|
|
| G
|
Lipc
|
lipase C, hepatic type
|
increases activity
|
EXP
|
Diosgenin results in increased activity of LIPC protein
|
CTD |
PMID:20149787 |
|
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions decreases lipidation
|
EXP ISO
|
[alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein; alpha-Chlorohydrin inhibits the reaction [Diosgenin results in decreased lipidation of MAP1LC3B protein] 3-methyladenine inhibits the reaction [[alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein]; [alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein; alpha-Chlorohydrin inhibits the reaction [Diosgenin results in decreased lipidation of MAP1LC3B protein]; bafilomycin A1 promotes the reaction [[alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein]; Diosgenin promotes the reaction [alpha-Chlorohydrin results in increased lipidation of MAP1LC3B protein]
|
CTD |
PMID:35149085 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Mesp1
|
mesoderm posterior bHLH transcription factor 1
|
decreases expression
|
ISO
|
Diosgenin results in decreased expression of MESP1 mRNA; Diosgenin results in decreased expression of MESP1 protein
|
CTD |
PMID:34806916 |
|
NCBI chr 1:143,147,671...143,149,189
Ensembl chr 1:143,147,671...143,149,189
|
|
| G
|
Mest
|
mesoderm specific transcript
|
multiple interactions decreases expression
|
ISO
|
Diosgenin inhibits the reaction [Dietary Fats results in increased expression of MEST mRNA] Diosgenin results in decreased expression of MEST mRNA
|
CTD |
PMID:26408789 |
|
NCBI chr 4:60,321,814...60,332,288
Ensembl chr 4:60,316,102...60,333,509
|
|
| G
|
Mfn1
|
mitofusin 1
|
multiple interactions
|
ISO
|
Diosgenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of MFN1 protein]
|
CTD |
PMID:35149085 |
|
NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:117,241,759...117,290,190
|
|
| G
|
Mfn2
|
mitofusin 2
|
multiple interactions
|
EXP ISO
|
Diosgenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of MFN2 protein]
|
CTD |
PMID:35149085 |
|
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
increases activity increases expression
|
EXP
|
Diosgenin results in increased activity of MMP2 protein Diosgenin results in increased expression of MMP2 mRNA
|
CTD |
PMID:21814480 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions decreases expression decreases activity
|
ISO EXP
|
Diosgenin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] Diosgenin results in decreased expression of MMP9 mRNA Diosgenin results in decreased activity of MMP9 protein
|
CTD |
PMID:16331273 PMID:21814480 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
multiple interactions
|
ISO EXP
|
3-methyladenine inhibits the reaction [Diosgenin promotes the reaction [alpha-Chlorohydrin results in decreased phosphorylation of MTOR protein]]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of MTOR mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased phosphorylation of MTOR protein]; Diosgenin inhibits the reaction [MTOR protein promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; Diosgenin promotes the reaction [alpha-Chlorohydrin results in decreased phosphorylation of MTOR protein]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN protein]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A protein]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA protein]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA protein]] Diosgenin inhibits the reaction [Dietary Fats results in increased expression of MTOR mRNA]; Diosgenin inhibits the reaction [Dietary Fats results in increased phosphorylation of MTOR protein]
|
CTD |
PMID:35149085 PMID:39536891 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
multiple interactions
|
ISO
|
Diosgenin inhibits the reaction [TNF protein results in increased expression of MYC protein]
|
CTD |
PMID:16331273 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions
|
ISO
|
Diosgenin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]
|
CTD |
PMID:16331273 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
Diosgenin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Diosgenin inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]
|
CTD |
PMID:16331273 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4
|
multiple interactions
|
EXP
|
Diosgenin affects the reaction [Dietary Fats affects the expression of NR1H4 mRNA]; Diosgenin affects the reaction [Dietary Fats affects the expression of NR1H4 protein]
|
CTD |
PMID:33383043 |
|
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
increases activity
|
ISO
|
Diosgenin results in increased activity of NR1I2 protein
|
CTD |
PMID:15611112 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
multiple interactions
|
EXP ISO
|
Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in increased degradation of NR3C1 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL6 protein]] Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of NR3C1 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH5 protein]]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of PECAM1 protein]]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]]
|
CTD |
PMID:39059093 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
multiple interactions
|
ISO EXP
|
Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of PECAM1 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of PECAM1 protein]]
|
CTD |
PMID:39059093 |
|
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
increases expression multiple interactions
|
ISO
|
Diosgenin results in increased expression of PIK3R1 mRNA [Diosgenin co-treated with Ecdysterone] results in increased expression of PIK3R1 mRNA
|
CTD |
PMID:39395682 |
|
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
increases expression decreases response to substance decreases expression multiple interactions
|
ISO
|
Diosgenin results in increased expression of PPARG protein Diosgenin results in increased expression of PPARG mRNA PPARG protein results in decreased susceptibility to Diosgenin Diosgenin results in decreased expression of PPARG mRNA [Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]] which results in decreased activity of PPARG protein; Diosgenin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]; Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]; fulvestrant inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA]; PPARG protein inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]; PPARG protein inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA]
|
CTD |
PMID:24001619 PMID:26408789 PMID:32347045 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO
|
Diosgenin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]
|
CTD |
PMID:16331273 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO EXP
|
Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA protein]; Diosgenin inhibits the reaction [TNF protein results in increased activity of RELA protein]; Diosgenin inhibits the reaction [TNF protein results in increased phosphorylation of and affects the localization of RELA protein]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA protein]] Diosgenin inhibits the reaction [Dietary Fats results in increased expression of RELA mRNA]; Diosgenin inhibits the reaction [Dietary Fats results in increased expression of RELA protein]; Diosgenin inhibits the reaction [Streptozocin results in increased expression of RELA mRNA]
|
CTD |
PMID:16331273 PMID:35305976 PMID:39536891 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Rhbdf2
|
rhomboid 5 homolog 2
|
multiple interactions
|
EXP
|
Diosgenin inhibits the reaction [Streptozocin results in increased expression of RHBDF2 mRNA]; Diosgenin inhibits the reaction [Streptozocin results in increased expression of RHBDF2 protein]
|
CTD |
PMID:35305976 |
|
NCBI chr10:102,331,991...102,359,117
Ensembl chr10:102,331,991...102,359,117
|
|
| G
|
Rps6kb1
|
ribosomal protein S6 kinase B1
|
multiple interactions
|
ISO
|
3-methyladenine inhibits the reaction [[Diosgenin co-treated with alpha-Chlorohydrin] results in decreased phosphorylation of RPS6KB1 protein]; [Diosgenin co-treated with alpha-Chlorohydrin] results in decreased phosphorylation of RPS6KB1 protein
|
CTD |
PMID:35149085 |
|
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238
|
|
| G
|
Rxra
|
retinoid X receptor alpha
|
multiple interactions
|
ISO
|
[Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]] which results in decreased activity of PPARG protein; Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]; Diosgenin promotes the reaction [RXRA protein binds to ESR2 protein]
|
CTD |
PMID:26408789 |
|
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
|
|
| G
|
Scarb1
|
scavenger receptor class B, member 1
|
multiple interactions
|
EXP
|
Diosgenin inhibits the reaction [Dietary Fats results in decreased expression of SCARB1 mRNA]; Diosgenin inhibits the reaction [Dietary Fats results in decreased expression of SCARB1 protein]
|
CTD |
PMID:33383043 |
|
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
|
|
| G
|
Stk11
|
serine/threonine kinase 11
|
multiple interactions
|
ISO
|
Diosgenin inhibits the reaction [alpha-Chlorohydrin results in decreased phosphorylation of STK11 protein]
|
CTD |
PMID:35149085 |
|
NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:10,225,204...10,241,965
|
|
| G
|
Tagln
|
transgelin
|
multiple interactions
|
EXP ISO
|
Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein] Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]]
|
CTD |
PMID:39059093 |
|
NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:55,121,301...55,127,563
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions decreases activity
|
ISO EXP
|
Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]; Diosgenin inhibits the reaction [TNF protein results in increased activity of AKT1 protein]; Diosgenin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]; Diosgenin inhibits the reaction [TNF protein results in increased activity of RELA protein]; Diosgenin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2 protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of BIRC2 protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of CFLAR protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of MYC protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of VEGFA protein]; Diosgenin inhibits the reaction [TNF protein results in increased phosphorylation of and affects the localization of RELA protein]; Diosgenin inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] Diosgenin inhibits the reaction [Dietary Fats results in increased expression of TNF protein]; Diosgenin inhibits the reaction [Streptozocin results in increased expression of TNF mRNA]; Diosgenin inhibits the reaction [Streptozocin results in increased expression of TNF protein] Diosgenin results in decreased activity of TNF protein
|
CTD |
PMID:16331273 PMID:35305976 PMID:39536891 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfsf11
|
TNF superfamily member 11
|
multiple interactions decreases activity
|
ISO
|
Diosgenin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] Diosgenin results in decreased activity of TNFSF11 protein
|
CTD |
PMID:16331273 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
|
|
| G
|
Ulk1
|
unc-51 like autophagy activating kinase 1
|
multiple interactions
|
ISO
|
3-methyladenine inhibits the reaction [[Diosgenin co-treated with alpha-Chlorohydrin] results in decreased phosphorylation of ULK1 protein]; [Diosgenin co-treated with alpha-Chlorohydrin] results in decreased phosphorylation of ULK1 protein
|
CTD |
PMID:35149085 |
|
NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions
|
ISO EXP
|
Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA protein]; Diosgenin inhibits the reaction [TNF protein results in increased expression of VEGFA protein]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA protein]] Diosgenin inhibits the reaction [Dietary Fats results in increased expression of VEGFA mRNA]; Diosgenin inhibits the reaction [Dietary Fats results in increased expression of VEGFA protein]
|
CTD |
PMID:16331273 PMID:39536891 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Wnt10b
|
Wnt family member 10B
|
decreases expression
|
ISO
|
Diosgenin results in decreased expression of WNT10B mRNA
|
CTD |
PMID:26408789 |
|
NCBI chr 7:131,801,046...131,806,850
Ensembl chr 7:131,801,046...131,806,850
|
|
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
decreases phosphorylation
|
ISO
|
solasodine results in decreased phosphorylation of AKT1 protein
|
CTD |
PMID:28283413 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Bche
|
butyrylcholinesterase
|
decreases activity
|
ISO
|
solasodine results in decreased activity of BCHE protein
|
CTD |
PMID:31152736 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Bsg
|
basigin
|
decreases expression
|
ISO
|
solasodine results in decreased expression of BSG mRNA
|
CTD |
PMID:28283413 |
|
NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions
|
ISO
|
solasodine results in increased cleavage of and results in decreased expression of CASP3 protein
|
CTD |
PMID:37121296 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp7
|
caspase 7
|
multiple interactions
|
ISO
|
solasodine results in increased cleavage of and results in decreased expression of CASP7 protein
|
CTD |
PMID:37121296 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
solasodine results in increased cleavage of and results in decreased expression of CASP9 protein
|
CTD |
PMID:37121296 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cdh1
|
cadherin 1
|
increases expression multiple interactions
|
ISO
|
solasodine results in increased expression of CDH1 protein CLDN2 protein inhibits the reaction [solasodine results in increased expression of CDH1 protein]
|
CTD |
PMID:37121296 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdh2
|
cadherin 2
|
decreases expression multiple interactions
|
ISO
|
solasodine results in decreased expression of CDH2 mRNA; solasodine results in decreased expression of CDH2 protein CLDN2 protein inhibits the reaction [solasodine results in decreased expression of CDH2 protein]
|
CTD |
PMID:37121296 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Cldn2
|
claudin 2
|
multiple interactions decreases expression
|
ISO
|
acadesine promotes the reaction [solasodine results in decreased expression of CLDN2 protein]; CLDN2 protein inhibits the reaction [solasodine results in decreased expression of CDH2 protein]; CLDN2 protein inhibits the reaction [solasodine results in decreased expression of VIM protein]; CLDN2 protein inhibits the reaction [solasodine results in increased expression of CDH1 protein] solasodine results in decreased expression of CLDN2 mRNA; solasodine results in decreased expression of CLDN2 protein
|
CTD |
PMID:37121296 |
|
NCBI chr X:108,248,383...108,258,847
Ensembl chr X:108,237,676...108,262,377
|
|
| G
|
Gpx4
|
glutathione peroxidase 4
|
decreases expression
|
ISO
|
solasodine results in decreased expression of GPX4 protein
|
CTD |
PMID:37121296 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP
|
solasodine inhibits the reaction [Ovalbumin results in increased secretion of IL1B protein]
|
CTD |
PMID:36084726 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il4
|
interleukin 4
|
multiple interactions
|
EXP
|
solasodine inhibits the reaction [Ovalbumin results in increased secretion of IL4 protein]
|
CTD |
PMID:36084726 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il5
|
interleukin 5
|
multiple interactions
|
EXP
|
solasodine inhibits the reaction [Ovalbumin results in increased secretion of IL5 protein]
|
CTD |
PMID:36084726 |
|
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
|
|
| G
|
Mir21
|
microRNA 21
|
decreases expression
|
ISO
|
solasodine results in decreased expression of MIR21; solasodine results in decreased expression of MIR21 mRNA
|
CTD |
PMID:28283413 PMID:37121296 |
|
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
decreases expression
|
ISO
|
solasodine results in decreased expression of MMP2 mRNA
|
CTD |
PMID:28283413 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
decreases expression
|
ISO
|
solasodine results in decreased expression of MMP9 mRNA
|
CTD |
PMID:28283413 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
ISO
|
solasodine results in increased cleavage of and results in decreased expression of PARP1 protein
|
CTD |
PMID:37121296 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Prkaa1
|
protein kinase AMP-activated catalytic subunit alpha 1
|
increases phosphorylation
|
ISO
|
solasodine results in increased phosphorylation of PRKAA1 protein
|
CTD |
PMID:37121296 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450
|
|
| G
|
Reck
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
increases expression
|
ISO
|
solasodine results in increased expression of RECK mRNA
|
CTD |
PMID:28283413 |
|
NCBI chr 5:62,898,717...62,965,274
Ensembl chr 5:62,898,668...62,965,270
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
decreases localization
|
ISO
|
solasodine results in decreased localization of RELA protein
|
CTD |
PMID:37121296 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Rhoa
|
ras homolog family member A
|
decreases expression
|
ISO
|
solasodine results in decreased expression of RHOA protein
|
CTD |
PMID:37121296 |
|
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302
|
|
| G
|
Slc7a11
|
solute carrier family 7 member 11
|
decreases expression
|
ISO
|
solasodine results in decreased expression of SLC7A11 protein
|
CTD |
PMID:37121296 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
decreases phosphorylation
|
ISO
|
solasodine results in decreased phosphorylation of STAT3 protein
|
CTD |
PMID:37121296 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression
|
ISO
|
solasodine results in increased expression of TIMP1 mRNA
|
CTD |
PMID:28283413 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Timp2
|
TIMP metallopeptidase inhibitor 2
|
increases expression
|
ISO
|
solasodine results in increased expression of TIMP2 mRNA
|
CTD |
PMID:28283413 |
|
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
EXP
|
solasodine inhibits the reaction [Ovalbumin results in increased secretion of TNF protein]
|
CTD |
PMID:36084726 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Vim
|
vimentin
|
decreases expression multiple interactions
|
ISO
|
solasodine results in decreased expression of VIM mRNA; solasodine results in decreased expression of VIM protein CLDN2 protein inhibits the reaction [solasodine results in decreased expression of VIM protein]
|
CTD |
PMID:37121296 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|